David Grinblatt to Drug Resistance, Neoplasm
This is a "connection" page, showing publications David Grinblatt has written about Drug Resistance, Neoplasm.
Connection Strength
0.056
-
Streamline: Retrospective Cohort Study of FMS-Like Tyrosine Kinase 3-Mutated Acute Myeloid Leukemia - Real-World Treatment Patterns and Clinical Outcomes of Patients in First Relapse or Refractory Diagnosis. Acta Haematol. 2026; 149(2):125-136.
Score: 0.042
-
Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas. Leuk Lymphoma. 2010 Jul; 51(7):1241-50.
Score: 0.015